An observational study in Sleep Disorders, sponsored by Itamar-Medical, Israel. Completed at 1 site in Israel. Open to participants aged 5 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-09-19.
Sponsored by Itamar-Medical, Israel · Observational
The prevalence of OSAS is estimated at 2% and 4% for adult women and men respectively, most of whom are undiagnosed and untreated. The severity of the disorder is expressed by the Apnea Hypopnea Index (AHI) which is the number of Apnea/Hypopnea episodes per hours of actual sleep and the Respiratory Disturbances Index (RDI) which is an extended index incorporating in addition to the previous episodes also respiratory effort related arousal episodes. The high cost of in-lab full night PSG, together with long waiting lists for sleep studies, have led to the development of a variety of ambulatory sleep study systems.
The primary objective of the study is to evaluate the newly developed WP200 with the unified probe (WP200U) compared to the currently used configuration of WP200 that uses an incorporated Nonin oximetry module in the sleep lab or in the home sleep environment.
788 studies on the registry are indexed under Sleep Wake Disorders; 186 are open to participants now.
This study's enrollment of 75 is below the median of 114 across 215 observational studies indexed under Sleep Wake Disorders.
Browse Sleep Wake Disorders studies →Itamar-Medical, Israel is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects, adults and children, with suspected sleep disorders who are referred to a sleep study and are willing to participate in this clinical study.
Additional non selective volunteers who are willing to participate in this clinical study and consent to undergo an overnight sleep study at their home.
Exclusion Criteria:
Sleep respiratory parameters
pRDI, pAHI, ODI
Time frame: 3 years
This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Itamar-Medical, Israel